Physio-Control Receives FDA Clearance For LIFEPAK 20e Defibrillator/Monitor

 

October 6, 2008

October 6, 2008 - Physio-Control Inc. last week announced FDA clearance to market the LIFEPAK 20e defibrillator/monitor in the U.S.

The 20e is an enhancement of the LIFEPAK 20 defibrillator/monitor, which has become the standard of care in many hospitals worldwide since its introduction in 2002. It offers all the capabilities of the LIFEPAK 20 device, along with a more powerful lithium-ion battery that doubles ECG monitoring time and the run time of other parameters such as noninvasive pacing and pulse oximetry, a noninvasive way to monitor the oxygenation of a patient’s hemoglobin. Additionally, a new on-screen “fuel gauge” displays the real-time status of available battery capacity so clinicians can monitor remaining use time.

The 20e is an enhancement of the LIFEPAK 20 defibrillator/monitor, offering a more powerful Lithium-ion battery that doubles ECG monitoring time and the run time of other parameters such as noninvasive pacing and pulse oximetry.

Physio-Control is currently under a consent decree with the FDA, which restricts the amount of products that can be delivered to customers. However, the company is permitted to manufacture and ship a limited selection of product under certain conditions to meet the critical needs of emergency response customers.


For more information: www.physio-control.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.